While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

Here are the side effects you should look out for. Common Moderna booster side effects include: The Pfizer-BioNTech booster ...

Booster shots are here — for some Americans, at least. US regulators have updated their recommendations as to who should get a third dose of Pfizer and Moderna's vaccines. The Food and Drug ...

Boosters aren’t currently recommended for anyone else in the U.S., though regulators and CDC officials will soon decide if any Moderna and Johnson & Johnson recipients should also get extra doses.

Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Moderna and Pfizer-BioNTech converted their vaccines from monovalent to bivalent. Approved for use in August 2022, these boosters contained two pieces of mRNA, one that coded for the spike protein ...

Now, what about the second booster, which, for people who received Pfizer and Moderna, would be their fourth shot? Who's eligible? Well, right now, you're eligible for a second COVID-19 booster if ...